jRCT2032220478进行中（未招募）不适用
A multicenter controlled trial of NP029 in patients with dialysis shunt insufficiency
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 130
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Single Blind
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •Patients aged >=20 years at the time of consent, etc.
排除标准
- •Patients who are judged by the investigator or subinvestigator to be unsuitable to participate in the study, etc.
结局指标
主要结局
-
Primary patency rate of target lesions up to 6 months after investigational procedure
次要结局
未报告次要终点
研究者
相似试验
招募中
4 期
A multicenter controlled trial of NP029 in patients with dialysis shunt insufficiencydialysis shunt failureJPRN-jRCT2032220478shima yasuhiro130
已完成
3 期
P028 clinical trialSuperficial femoral artery and/or popliteal artery diseaseJPRN-jRCT1080224100IPRO CORPORATIO207
招募中
1 期
Phase I/II clinical trial of NZ-C1909Degenerative lumbar diseasesJPRN-jRCT2031220509Okawa Atsushi24
已完成
2 期
Multicenter Phase II Clinical Study of the research on optimal assessments and treatment strategy of nilotinib in newly diagnosed chronic myelogenous leukemia patients in the chronic phase (CML-CP) based on early achievement of complete molecular response (CMR); N-roadChronic Myelogenous LeukemiaJPRN-UMIN000008565Cooperative study between Jikei University Kashiwa Hospital and Shimousa Hematology Study Group50
招募中
不适用
A multicenter controlled clinical trial on the improvement of sepsis-associated CCI muscular dystrophy by time-sharing administration(Day-3-Night-2) of Huanglian DecoctioSepsis-related Chronic Care IllnessesITMCTR2024000045Jiangsu Provincial Hospital of Chinese Medicine